Chronic Heart Failure: Ferric Derisomaltose Treatment

We are studying whether ferric derisomaltose can improve heart health and reduce hospitalizations in people with iron deficiency and chronic heart failure. This trial compares it to no intravenous iron treatment.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Ferric Derisomaltose Pharmacosmos
Ferric Derisomaltose Pharmacosmos is an injection medicine used to treat iron deficiency anemia when oral iron doesn't work.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ferric Derisomaltose
Ferric derisomaltose is a substance that restores iron levels in people with iron deficiency anemia when oral iron is not effective.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Monofer

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Diafer
Monofar
Monofer

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Mnogoprofilna Bolnitsa Za Aktivno Lechenie Puls AD
Department of Cardiology
Blagoevgrad, Bulgaria
Multiprofile Hospital For Active Treatment Dr. Tota Venkova AD
Cardiology Department
Gabrovo, Bulgaria
Multidisciplinary Hospital For Active Treatment Haskovo AD
Department of Cardiology
Haskovo, Bulgaria

Sponsor: Pharmacosmos A/S
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.